GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gelesis Holdings GLSHQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Gelesis Holdings — daily GLSHQ Delayed
Market value
$7,334
Last close × shares
Volume
200
Shares, 30 Oct 2026

About Gelesis Holdings

Its shares trade under the ticker GLSHQ. It has been listed since 7 July 2020. In the fiscal year to 31 December 2022, it reported revenue of $25.8m and a net loss of $57.1m. At that date it held total assets of $103.3m and shareholders' equity of −$25.1m.

Gelesis Holdings, Inc. operates as a biotechnology company. The company is headquartered in Boston, Massachusetts. The company went IPO on 2020-07-07. The firm focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. The company is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).

Figures and description from our data supplier, not checked against the company's own report.

More about Gelesis Holdings →

Latest on Gelesis Holdings

Our reporting

We have not reported on Gelesis Holdings yet.

Next results

16 Nov 2026

Due on 16 Nov 2026. Analysts expect earnings of -0.34 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Gelesis Holdings's ticker?

Gelesis Holdings trades as GLSHQ on its US listing, under ISIN US36850R2040.

What was Gelesis Holdings's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

When does Gelesis Holdings next report results?

Results are expected on 16 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.